O
Oktar Asoglu
Publications - 2
Citations - 688
Oktar Asoglu is an academic researcher. The author has contributed to research in topics: Cancer & Risk assessment. The author has an hindex of 2, co-authored 2 publications receiving 344 citations.
Papers
More filters
Journal ArticleDOI
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J M van der Valk,Maxime J M van der Valk,Denise E. Hilling,Denise E. Hilling,Esther Bastiaannet,Elma Meershoek-Klein Kranenbarg,Geerard L. Beets,Geerard L. Beets,Nuno Figueiredo,Angelita Habr-Gama,Rodrigo Oliva Perez,Andrew G Renehan,Andrew G Renehan,Cornelis J.H. van de Velde,Madeleine Ahlberg,Ane L Appelt,Oktar Asoglu,Maria-Theresa Bär,Rita Barroca,Regina G. H. Beets-Tan,Eric Belgers,Robbert J I Bosker,Stephanie O. Breukink,Krysztof Bujko,Carlos Carvalho,Christopher M. Cunningham,Ben Creavin,André D’Hoore,Jean-Pierre Gerard,Simon Gollins,Christiaan Hoff,Fabian A. Holman,Britt J. P. Hupkens,Soledad Iseas,Anders Jakobsen,Amir Keshvari,Sietze A Koopal,Miranda Kusters,Melanie Langheinrich,Jeroen W. A. Leijtens,Monique Maas,Lee Malcomson,Zamam Z Mamedli,Anna Martling,Klaus E. Matzel,Jarno Melenhorst,María L Morici,Sthela M. Murad-Regadas,Sarah T O'Dwyer,Koen C.M.J. Peeters,Isadora Rosa,Gustavo Rossi,Harm J. T. Rutten,Fernando Sanchez Loria,Marit E van der Sande,Guilherme Pagin São Julião,Mark P Saunders,Arthur Sun Myint,Hedwig van der Sluis,Renaud Schiappa,Nigel Scott,Jan H.M.B. Stoot,A Koen Talsma,Isabelle Terrasson,Handan Tokmak,Carlos A. Vaccaro,Alexander L Vahrmeijer,Daria K Wasowicz,Henderik L Westreenen,Des C. Winter,Albert Wolthuis,David D. E. Zimmerman +71 more
TL;DR: This dataset has the largest series of patients with rectal cancer treated with a W&W approach, consisting of approximately 50% data from previous cohort series and 50% unpublished data.
Journal ArticleDOI
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
Laura M. Fernandez,Guilherme Pagin São Julião,Nuno Figueiredo,Geerard L. Beets,Geerard L. Beets,Maxime J M van der Valk,Renu R. Bahadoer,Denise E. Hilling,Denise E. Hilling,Elma Meershoek-Klein Kranenbarg,Annet G H Roodvoets,Andrew G Renehan,Andrew G Renehan,Cornelis J.H. van de Velde,Angelita Habr-Gama,Rodrigo Oliva Perez,A. Abdelrazeq,Oktar Asoglu,Rita Barroca,J. Beveridge,A. Bhowmick,A. Blower,M. Braun,Krzysztof Bujko,P. Carter,Carlos Alfredo Lopes de Carvalho,Claudio Coco,Christopher M. Cunningham,André D’Hoore,Gabriel Dimofte,Peirong Ding,S. Duff,S.T. Dwyer,J. Epstein,D. Evans,Paul E Fulford,Wolfgang Gaertner,Jean-Pierre Gerard,Simon Gollins,R. Harris,J. Harrison,J. Heat,James Hill,J. Hobbiss,Eduardo Huertas,Z. Huq,Soledad Iseas,Anders Jakobsen,David R. Jones,L. Jones,U. Khan,R. Kushwaha,N. Lees,T.Y. Linn,S. Loganathan,Fernando López Campos,Robert Madoff,Zaman Z. Mamedli,Anna Martling,Klaus E. Matzel,Jarno Melenhorst,P. Mitchell,Sthela M. Murad-Regadas,Sarah T O'Dwyer,Alejandro Pairola,M. Paraoan,Oriol Pares,Koen C.M.J. Peeters,S.H. Pettit,Nagarajan Pranesh,R. Rajaganeshan,S. Ravi,S. Rawat,D. Richards,K. Riyad,Gustavo Rossi,Harm J. T. Rutten,M. Saeed,J. Salaman,Fernando Sanchez Loria,Marit E van der Sande,Inês Santiago,Chelliah Selvasekar,K.H. Siddiqui,C. Smart,M.H. Solkar,Arthur Sun Myint,B. Taylor,K. Telford,Nigel Scott,Carlos A. Vaccaro,Bruna Borba Vailati,Charlotte Verberne,P. Vieira,D. Vimalchandran,S. Ward,Malcolm S Wilson,Des C. Winter,Carlijn Witjes,Albert Wolthuis,Jing Zhang,Zhen Zhang +101 more
TL;DR: The results suggest that the intensity of active surveillance in patients with rectal cancer managed by a watch-and-wait approach could be reduced if they achieve and maintain a clinical complete response within the first 3 years of starting this approach.